KMTS · NASDAQ
Kestra Medical Technologies (KMTS) Stock Price & Fundamentals
Kestra Medical Technologies (KMTS) closed at $427.13 on Oct 9, 2026, up 0.61% from the previous close of $424.55.
Share price, past year
1Y +46.93%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $427.13 |
| Sep 30, 2026 | $410.97 |
| Aug 31, 2026 | $375.37 |
| Jul 31, 2026 | $396.73 |
| Jun 30, 2026 | $371.19 |
| May 29, 2026 | $337.51 |
| Apr 30, 2026 | $321.60 |
| Mar 31, 2026 | $314.31 |
| Feb 27, 2026 | $335.28 |
| Jan 30, 2026 | $335.04 |
| Dec 31, 2025 | $316.63 |
| Nov 28, 2025 | $322.57 |
| Oct 31, 2025 | $300.56 |
Key statistics
- Market cap
- $25.32B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.68
- Revenue (TTM)
- $106.73M
- Net income (TTM)
- −$149.87M
- Shares outstanding
- 59.3M
- Dividend yield
- —
- 52-week range
- $287.72 – $427.13
Kestra Medical Technologies's market cap is $25.32B, based on a share price of $427.13 and 59.3M shares outstanding as of Jul 31, 2026.
Financials
Kestra Medical Technologies reported revenue of $95.13M for fiscal 2026, up 59.03% from fiscal 2025.
Kestra Medical Technologies reported a net loss of $131.61M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Apr 30, 2026 | $95.13M | +59.0% | −$131.61M | −138.4% | −$2.43 | −$116.60M |
| FY2025ended Apr 30, 2025 | $59.82M | +115.1% | −$113.81M | −190.3% | −$5.13 | −$100.54M |
| FY2024ended Apr 30, 2024 | $27.81M | — | −$94.12M | −338.4% | −$5.07 | −$84.46M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Jul 31, 2026 | $30.97M | −$44.09M | −$0.75 |
| Q4 FY2026ended Apr 30, 2026 | $28.64M | −$38.84M | −$0.68 |
| Q3 FY2026ended Jan 31, 2026 | $24.55M | −$34.17M | −$0.61 |
| Q2 FY2026ended Oct 31, 2025 | $22.57M | −$32.79M | −$0.64 |
| Q1 FY2026ended Jul 31, 2025 | $19.37M | −$25.83M | −$0.50 |
| Q4 FY2025ended Apr 30, 2025 | $17.23M | −$52.05M | −$1.57 |
| Q3 FY2025ended Jan 31, 2025 | $15.09M | −$21.51M | −$1.25 |
| Q2 FY2025ended Oct 31, 2024 | $14.71M | −$20.37M | −$1.19 |
Company profile
- Name
- Kestra Medical Technologies, Ltd.
- Ticker
- KMTS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 3933 Lake Washington Blvd Ne, Suite 200, Kirkland, WA 98033
- Incorporated in
- D0
- Fiscal year ends
- April
- SEC CIK
- 0001877184
Recent SEC filings
- Sep 14, 2026
- Sep 14, 2026
- Sep 10, 2026
- Jul 14, 2026
- Jul 14, 2026
- Mar 17, 2026
- Mar 17, 2026
- Dec 11, 2025
Frequently asked questions
What is Kestra Medical Technologies's stock price?
Kestra Medical Technologies (KMTS) closed at $427.13 on Oct 9, 2026, up 0.61% from the previous close of $424.55.
What is Kestra Medical Technologies's market cap?
Kestra Medical Technologies's market cap is $25.32B, based on a share price of $427.13 and 59.3M shares outstanding as of Jul 31, 2026.
How much revenue does Kestra Medical Technologies make?
Kestra Medical Technologies reported revenue of $95.13M for fiscal 2026, up 59.03% from fiscal 2025.
Does Kestra Medical Technologies pay a dividend?
Kestra Medical Technologies's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Kestra Medical Technologies, Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures